Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision tag updated to v3.4.3, replacing the prior v3.4.2.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.2 is now displayed on the page, and the previous funding-status notice as well as Revision: v3.4.1 have been removed. No study content, eligibility criteria, or user actions are affected by this change.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, informing users that the NIH Clinical Center is open and linking to cc.nih.gov and opm.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedAdds a glossary toggle (Show glossary) and exposes revised metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a new revision label (Revision: v3.4.0). The older QC criteria wording, the older FEAR Act wording (No FEAR Act data), and the previous revision tag (Revision: v3.3.4) are removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive content changes are visible in the screenshot; this appears to be a backend version update.SummaryDifference0.0%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.